TGFB1 and neoplasm: To assess changes in the expression of immunosuppressive markers on sEVs isolated from HNC patients after tumor treatment, the presence of PD-1, PD-L1 and TGF-β1 was evaluated during patient control examination, three (R1) and six (R2) months after completion of tumor therapy (R = Recall).